Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation.
De Witte
T
T
Department of Internal Medicine, University Hospital St Radboud, Nijmegen, The Netherlands.
Vreugdenhil
G
G
Schattenberg
A
A
D016026:Bone Marrow Transplantation / Q000473:pathology*; D004311:Double-Blind Method; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000601:surgery; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery; D015470:Leukemia, Myeloid, Acute / Q000601:surgery; D007958:Leukocyte Count / Q000187:drug effects; D008212:Lymphocyte Depletion; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000601:surgery; D011994:Recombinant Proteins / Q000008:administration & dosage; D012008:Recurrence; D013997:Time Factors
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor